Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2000 3
2001 3
2002 4
2003 3
2004 5
2005 7
2006 6
2007 8
2008 10
2009 10
2010 11
2011 7
2012 11
2013 5
2014 7
2015 11
2016 9
2017 9
2018 12
2019 7
2020 6
2021 3
2022 3
2023 1
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for van tendeloo v
Search for Vantendeloo V instead (1 results)
Shared lung and joint T cell repertoire in early rheumatoid arthritis driven by cigarette smoking.
Venken K, Jarlborg M, Stevenaert F, Malfait TLA, Vlieghe C, Abraham Y, Manuello T, Decruy T, Vanhee S, Wils H, Peeters PJ, Carron P, Van den Bosch F, Van Tendeloo V, Lambrecht BN, Wittoek R, Jacques P, Elewaut D. Venken K, et al. Among authors: van tendeloo v. Ann Rheum Dis. 2024 Nov 8:ard-2024-226284. doi: 10.1136/ard-2024-226284. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39521450
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.
Berneman ZN, De Laere M, Germonpré P, Huizing MT, Willemen Y, Lion E, De Reu H, Van den Bossche J, Van den Brande J, Specenier P, Altintas S, van Dam PA, Cools N, Nijs G, Stein B, Caluwaerts K, Snoeckx A, Op de Beeck B, Saevels K, Rutsaert L, Vandenbosch I, Oner G, Lammens M, Van Damme P, Llewellyn-Lacey S, Price DA, Oka Y, Oji Y, Sugiyama H, Couttenye MM, Van de Velde AL, Van Tendeloo VF, Peeters M, Anguille S, Smits ELJM. Berneman ZN, et al. Among authors: van tendeloo vf. J Hematol Oncol. 2025 Jan 23;18(1):9. doi: 10.1186/s13045-025-01661-x. J Hematol Oncol. 2025. PMID: 39849594 Free PMC article. Clinical Trial.
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.
Van Acker HH, Versteven M, Lichtenegger FS, Roex G, Campillo-Davo D, Lion E, Subklewe M, Van Tendeloo VF, Berneman ZN, Anguille S. Van Acker HH, et al. Among authors: van tendeloo vf. J Clin Med. 2019 Apr 27;8(5):579. doi: 10.3390/jcm8050579. J Clin Med. 2019. PMID: 31035598 Free PMC article. Review.
CD56 in the Immune System: More Than a Marker for Cytotoxicity?
Van Acker HH, Capsomidis A, Smits EL, Van Tendeloo VF. Van Acker HH, et al. Among authors: van tendeloo vf. Front Immunol. 2017 Jul 24;8:892. doi: 10.3389/fimmu.2017.00892. eCollection 2017. Front Immunol. 2017. PMID: 28791027 Free PMC article. Review.
Unraveling the Immune Signature of Herpes Zoster: Insights Into the Pathophysiology and Human Leukocyte Antigen Risk Profile.
Vandoren R, Boeren M, Schippers J, Bartholomeus E, Mullan K, Michels N, Aerts O, Leysen J, Bervoets A, Lambert J, Leuridan E, Wens J, Peeters K, Emonds MP, Jansens H, Casanova JL, Bastard P, Suls A, Van Tendeloo V, Ponsaerts P, Delputte P, Ogunjimi B, Laukens K, Meysman P. Vandoren R, et al. Among authors: van tendeloo v. J Infect Dis. 2024 Sep 23;230(3):706-715. doi: 10.1093/infdis/jiad609. J Infect Dis. 2024. PMID: 38195164 Free PMC article.
Antigen-specific cellular immunotherapy of leukemia.
Van Driessche A, Gao L, Stauss HJ, Ponsaerts P, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF. Van Driessche A, et al. Among authors: van tendeloo vf. Leukemia. 2005 Nov;19(11):1863-71. doi: 10.1038/sj.leu.2403930. Leukemia. 2005. PMID: 16121214 Review.
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?
van Ee TJ, Van Acker HH, van Oorschot TG, Van Tendeloo VF, Smits EL, Bakdash G, Schreibelt G, de Vries IJM. van Ee TJ, et al. Among authors: van tendeloo vf. Vaccines (Basel). 2018 Sep 19;6(3):65. doi: 10.3390/vaccines6030065. Vaccines (Basel). 2018. PMID: 30235890 Free PMC article. Review.
Dendritic cell-based cancer gene therapy.
Smits EL, Anguille S, Cools N, Berneman ZN, Van Tendeloo VF. Smits EL, et al. Among authors: van tendeloo vf. Hum Gene Ther. 2009 Oct;20(10):1106-18. doi: 10.1089/hum.2009.145. Hum Gene Ther. 2009. PMID: 19656053 Review.
Clinical use of dendritic cells for cancer therapy.
Anguille S, Smits EL, Lion E, van Tendeloo VF, Berneman ZN. Anguille S, et al. Among authors: van tendeloo vf. Lancet Oncol. 2014 Jun;15(7):e257-67. doi: 10.1016/S1470-2045(13)70585-0. Lancet Oncol. 2014. PMID: 24872109 Review.
153 results